Navigation Links
Huifeng Bio-Pharmaceutical (HFGB) Announces Participation in the 59th PHARMCHINA Expo
Date:4/18/2008

XI'AN, China, April 18 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio- Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced that it participated in the 59th biannual PHARMCHINA Expo held in Xi'an, China from April 15-17.

With an exhibition area of 45,000 sq. meters, attracting over 1,500 exhibitors and 100,000 professionals, PHARMCHINA (the China National Pharmaceuticals Fair) is the largest pharmaceutical fair in China. Held twice a year, with a history of nearly 30 years, it has become a can't miss event for all professionals interested in Traditional Chinese Medicine, Neutraceuticals and Pharmaceuticals in the People's Republic of China.

While at the conference, Huifeng is pleased to announce the signing of contracts with three new customers for its main products of Rutin, Troxerutin and Quercetin. The total value of these contracts is estimated at $600,000 in 2008.

About Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB)

Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. http://www.hfgb.cn/

For more information, please contact:

Dan Carlson

Primary Capital LLC

Email:

SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Skystar Bio-Pharmaceutical Announces Upcoming Interview With WallSt.net ( www.wallst.net )
2. Zimmer Announces New Compliance Model
3. The Alliance for Lupus Research Announces 2008 Grantees
4. TeamStaff, Inc. Announces Results From Annual Meeting of Shareholders
5. CTG Announces 2008 First Quarter Conference Call and Webcast Information
6. Heartland Information Services Announces Alliance with M*Modal
7. Access Pharmaceuticals Announces New Data on Angiolix(R)
8. Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
9. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
10. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
11. DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...ecedented medical, economic burdens, study predict...- The number of people with diabetes in the United...rs, a new study predicts. , That would bring th...the disease, up from 23.7 million today. , , At ...abetes will triple, the study also warns, rising f...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...ission Includes Clinical Data Demonstrating Superi...R) Drug Eluting Stent, TOKYO, June 2 Abbott (NYS... application for Seizo Hanbai Shonin,(Marketing Au...its XIENCE(TM) V Everolimus Eluting Coronary Stent...
..., June 2 Treating pancreatic cancer with a combin... prior to surgery is safe and may be beneficial fo...h Cancer Institute (UPCI) study presented at the 4...nter of the University of Pittsburgh Medical Cente...
..., Ill., June 2 With all the concerns about,what,s...even more attention,these days to what we are givi...ng a few precautions. After all, pet,food recalls ...cording to a study in the June 1, 2008, Journal of...
..., June 2 Kensey Nash Corporation,(Nasdaq: KNSY )...sale of its,endovascular business to Spectranetics... 30, 2008. This transaction includes the sale of t...ts of the Kensey Nash and Spectranectics transitio...
...dney Care Provider Recognized by the Association o... Inspiring Tales of Patient and Teammate ...., June 2 DaVita Inc., a leading,provider of kidn...gazine: Stories from the Village, received two,pre...
...BUS, Ohio) Bunk bed-related injuries are not an i...en according to a study conducted by investigators...he Research Institute at Nationwide Childrens Hosp...unger than 10 years of age, there is a surprising ...
Other Medicine News:Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 2Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 4Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 5Health News:New treatment combination safe for pancreatic cancer patients 2Health News:Is Tap Water Safe for Your Dog? 2Health News:Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics 2Health News:Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics 3Health News:DaVita Magazine Takes Home Two Prestigious Hermes Creative Awards 2Health News:Bunk beds pose dangers to kids and adults 2Health News:Bunk beds pose dangers to kids and adults 3
(Date:11/25/2009)...25 Heska Corporation ( H...diagnostic and specialty products to the veterinar...Diagnostics Corporation for the supply of blood ga...rinary market. ,, (Logo: http://www.newsco...ka and Roche share the same passion for innovating...
(Date:11/25/2009)...-BioTrendsResearchGroup,Inc.releasedWave1ofits La...i-phasesyndicatedmarketresearchprojecttrackingthel...aunchthroughthefirstsixmonthsofavailability.Eachwa...uniqueDermatologistsandqualitativeinformationfroma...staclestouse,typicalpatienttypes,productperception...
(Date:11/25/2009).... 25 Regado Biosciences, a private...ombotic aptamers with active control agents, annou...l be presenting at the Piper Jaffray 21st Annual H... in New York City. Dr. Mazzo,s presentation will ...d will include an overview of the Company,s pipeli...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Study to Investigate AHCC and the Swine Flu Virus 47555 1Study to Investigate AHCC and the Swine Flu Virus 47555 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 1Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 2Go Red For Women 28R 29 Launches 12 Week Program to Improve Heart Health and Save Lives 47553 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 1Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 2Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 3Consumer Reports 3A Hearing Aid Shoppers Pay High Prices Get Mediocre Fittings 47551 4
...lly relevant model of,normal human skin found that...g the cytotoxic effect of erlotinib * Phase I sing...generally well,tolerated in metastatic melanoma pa...nventional vincristine , SOUTH SAN FRANCISCO, Cali...ces (Nasdaq:HNAB), a biopharmaceutical company foc...
... – Genta,Incorporated (Nasdaq: GNTA) announc...ical trial of its marketed product, Ganite®,(g...®;,Genentech/IDEC) and dexamethasone in patien... lymphoma (NHL). The data were,presented at the an...ncology (ASCO) in Chicago, IL. , ,Previously publi...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
Acuvue Toric
Binocular Loupes
Near Functional Acuity - Fact101
Near Point Card/Newspaper 8 to 48 - BC2203
Medicine Products: